| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/14/2002 | WO2001047918A3 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides |
| 03/14/2002 | WO2001047551A3 Eliciting antibodies specific for hepatitis c virus (hcv) |
| 03/14/2002 | WO2001045762A3 Wound healing medical pharmaceutical product |
| 03/14/2002 | WO2001045715A3 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain |
| 03/14/2002 | WO2001045684A3 Formulations of adenosine a1 agonists |
| 03/14/2002 | WO2001045683A3 Formulations of adenosine a1 agonists |
| 03/14/2002 | WO2001045682A3 Formulations of adenosine a1 agonists |
| 03/14/2002 | WO2001036684A3 Mammalian toxicological response markers |
| 03/14/2002 | WO2001034113A3 Apparatus and method for preparing microparticles |
| 03/14/2002 | WO2001032161A3 Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | WO2001030327A3 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions |
| 03/14/2002 | WO2001028541A3 Composition comprising sildenafil and l-arginine |
| 03/14/2002 | WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 03/14/2002 | WO2001022982A3 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 03/14/2002 | WO2001021651A3 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/14/2002 | WO2001021194A3 Method for the therapeutic management of endometriosis and fallopian tube obstruction |
| 03/14/2002 | WO2001002018A3 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 03/14/2002 | WO2000074662A3 Arthritis treatment |
| 03/14/2002 | WO2000066608A9 Tumor necrosis factor-gamma |
| 03/14/2002 | WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 03/14/2002 | US20020032464 Adhesion prevention and an endoscopic insufflation system therefor |
| 03/14/2002 | US20020032463 Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue |
| 03/14/2002 | US20020032332 Hypotensive agents, antiallergens, antiasthma, treating bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorder, gastrointestinal motility or cardiovascular disorders |
| 03/14/2002 | US20020032329 Method for the preparation of tetrahydrobenzothiepines |
| 03/14/2002 | US20020032328 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides |
| 03/14/2002 | US20020032326 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743 |
| 03/14/2002 | US20020032324 Process for the preparation of endotoxin-free or endotoxin-depleted nucleic acids and/or oligonucleotides for gene therapy |
| 03/14/2002 | US20020032307 Hepadnavirus pre-S protein fragments |
| 03/14/2002 | US20020032306 Cyclopeptide derivatives |
| 03/14/2002 | US20020032245 Ion exchange resin loaded with an active substance anisotropically distributed throughout said ion exchange resin particle; rapid release |
| 03/14/2002 | US20020032240 Preferably administered along with a basic permeation enhancer and a hydroxide-releasing agent such as sodium hydroxide. |
| 03/14/2002 | US20020032239 Treating pain, urinary incontinence, diarrhea or pruritus |
| 03/14/2002 | US20020032237 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 03/14/2002 | US20020032236 Method for the treatment of dermatological diseases by using nimesulide |
| 03/14/2002 | US20020032235 Anti-inflammatory method |
| 03/14/2002 | US20020032234 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative |
| 03/14/2002 | US20020032231 Viscous gel |
| 03/14/2002 | US20020032229 Novel compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 03/14/2002 | US20020032228 Inhibiting adenylate cyclase with a composition comprising an amount of a heterocycle-containing compound (e.g., imidazole, Celebrex or DuP-697) effective to inhibit the generation of cAMP from ATP |
| 03/14/2002 | US20020032226 Amorphous 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole compound, free of crystals; improved water solubility; treatment of COX-2 mediated disorders. |
| 03/14/2002 | US20020032225 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 03/14/2002 | US20020032224 Treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system disorders |
| 03/14/2002 | US20020032221 Treatment of HIV mediated diseases. |
| 03/14/2002 | US20020032220 The solutions are used to fill capsules, or self-supporting solid solutions are shaped into solid dosage forms such as tablets or pellets. |
| 03/14/2002 | US20020032219 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 03/14/2002 | US20020032218 Substituted stilbenes as glucose uptake enhancers |
| 03/14/2002 | US20020032217 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 03/14/2002 | US20020032215 Concurrent administration of acetaminophen with an azapirone such as buspirone. |
| 03/14/2002 | US20020032214 Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound |
| 03/14/2002 | US20020032213 Macrolides |
| 03/14/2002 | US20020032212 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 03/14/2002 | US20020032211 Novel dihydronaphthalene compounds and processes of producing the same |
| 03/14/2002 | US20020032210 Chloride channel blockers; useful in the treatment of sickle cell anaemia, brain edema following iscaemia or tumors, diarrhea, hypertension, bone metabolic disorders, osteoclast associated disoders; substituted biphenyl containing nitrogen |
| 03/14/2002 | US20020032209 Regulating apoptosis in human cells comprising exposing said cells to an effective amount of a 2,9-disubstituted purine-6 one compound |
| 03/14/2002 | US20020032208 Chemical compounds |
| 03/14/2002 | US20020032206 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 03/14/2002 | US20020032205 An alkyl amine substituted isobenzofuran compound useful for certain psychiatric and neurological disorders; potently binding to the 5-HT1A receptor |
| 03/14/2002 | US20020032204 Reacting a substituted indol-2-one compound with an acyclic or cyclic amine free of piperidine-1-yl or morpholine-4-yl to form protein kinase inhibitor |
| 03/14/2002 | US20020032203 Composition and method for decreasing neurologic symptomatology |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032201 Compositions containing alpha-2-adrenergic agonist components |
| 03/14/2002 | US20020032199 5-HT7 receptor antagonists |
| 03/14/2002 | US20020032197 Methods and compositions for using moclobemide |
| 03/14/2002 | US20020032196 CRF receptor antagonists and methods relating thereto |
| 03/14/2002 | US20020032194 CRF receptor antagonists and methods relating thereto |
| 03/14/2002 | US20020032193 3-substituted amino-4H-thieno(3, 2-e)-1,2,4-thiadiazine 1,1-dioxide is useful to protect the beta cells against toxic damage, for treating or preventing diseases related to autoimmune destruction of human beta cell |
| 03/14/2002 | US20020032192 Treatment of vasodilatory headache |
| 03/14/2002 | US20020032191 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 03/14/2002 | US20020032190 Contacting host with a cephalotaxine and an antiproliferative agent such as an alkylating agent, an intercalating agent, a metal coordination complex, a nucleoside, a nucleic acid enyme or protein inhibitor to modulate cell proliferation |
| 03/14/2002 | US20020032188 Compositions and methods for treatment of anal fissure |
| 03/14/2002 | US20020032187 Method for stimulating bone formation |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/14/2002 | US20020032185 Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient |
| 03/14/2002 | US20020032183 Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as JNK-inhibitors |
| 03/14/2002 | US20020032181 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020032179 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder |
| 03/14/2002 | US20020032177 Use of D-chiro-inositol in the treatment of conditions associated with hypothalamic gene expression |
| 03/14/2002 | US20020032176 Carcinogenesis inhibitors |
| 03/14/2002 | US20020032174 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 03/14/2002 | US20020032173 Blood flow improvers and thrombosis preventives or remedies |
| 03/14/2002 | US20020032172 Administering to the respiratory tract a polysaccharide for clearing mucus |
| 03/14/2002 | US20020032170 Underivatized, aqueous soluble beta (1-3) glucan, composition and method of making same |
| 03/14/2002 | US20020032169 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
| 03/14/2002 | US20020032164 For sanitizing surfaces |
| 03/14/2002 | US20020032161 Cyclodextrin compositions |
| 03/14/2002 | US20020032160 Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
| 03/14/2002 | US20020032158 Having anti-tumor activity and immunostimulating activity |
| 03/14/2002 | US20020032156 Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders |
| 03/14/2002 | US20020032152 Anti-helicobacter vaccine complex |
| 03/14/2002 | US20020032151 Using an agent which promotes tyrosine protein dephosphorylation in the preparation of a medicament for reducing permeability of a physiological barrier such as the blood-brain barrier |
| 03/14/2002 | US20020032149 Monitoring blood flow parameter of bloodstream, administering substance to organism such that an amount of substance enters bloodstream; distributing portion of amount ofsubstance target within organism |
| 03/14/2002 | US20020032148 Pharmaceutical agent containing Rho kinase inhibitor |
| 03/14/2002 | US20020032134 Detergent cosmetic compositions and use thereof |
| 03/14/2002 | US20020032111 Concentric tubular centrifuge |
| 03/14/2002 | US20020031819 Screening process for antibacterial agents |
| 03/14/2002 | US20020031816 Method of inhibition of human glycogen phosphorylase |
| 03/14/2002 | US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 03/14/2002 | US20020031781 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 03/14/2002 | US20020031563 Plant extracts |